Opinion

In re Novartis and Par Antitrust Litigation

Court
District Court, S.D. New York
Filed
May 25, 2022
Cited by
0 cases
Authority
More cited than 27.5%

The opinion

UNITED STATES DISTRICT COURT

SOUTHERN DISTRICT OF NEW YORK

-------------------------------------------------------------- X

:

:

: ORDER GRANTING MOTIONS

: TO SEAL

IN RE NOVARTIS AND PAR ANTITRUST :

LITIGATION : 18 Civ. 4361 (AKH)

:

:

:

:

-------------------------------------------------------------- X

ALVIN K. HELLERSTEIN, U.S.D.J.:

There are currently multiple motions to seal pending before me. In ECF Nos. 468

and 472, Plaintiffs request to seal and redact certain documents in connection with Daubert

motions. Similarly, in ECF Nos. 747 and 485 Defendants request to seal and redact documents

in connection with Daubert motions. In connection with class certification, Plaintiffs,

Defendants, and various non-parties request to seal certain documents and redact portions of

documents, as follows:

• ECF No. 514, filed by Defendant Par Pharmaceutical, Inc.;

• ECF No. 517, filed by non-party AmerisourceBergen Drug Corporation;

• ECF No. 518, filed by Plaintiff CVS Pharmacy, Inc.;

• ECF No. 519, filed by Plaintiffs Walgreen Co. and H-E-B, L.P.;

• ECF No. 520, filed by Defendants Novartis Pharmaceuticals Corporation and

Novartis AG;

• ECF No. 521, filed by non-party Cardinal Health, Inc.;

• ECF No. 525, filed by End-Payor Plaintiffs;

• ECF Nos. 529 and 542, filed by non-party Express Scripts, Inc.;

• ECF No. 533, filed by Direct Purchaser Class Plaintiffs;

• ECF No. 534, Ex. A, filed by Direct Purchaser Class Plaintiffs on behalf of

McKesson Corporation; and

• ECF Nos. 536, filed by non-party Mylan Pharmaceuticals, Inc.

No party or non-party objects to the requests made in any of the above-referenced motions to

seal.

In order to “overcome the First Amendment right of access,” the proponent of

sealing judicial documents bears the burden of showing that “closure is essential to preserve

higher values and is narrowly tailored to serve that interest.” Bernstein v. Bernstein Litowitz

Berger & Grossman LLP, 814 F.3d 132, 144 (2d Cir. 2016) (quoting In re N.Y. Times Co., 828

F.2d 110, 116 (2d Cir. 1987)). In particular, the need to maintain secrecy for sensitive business

information and practices can “outweigh the presumption of public access.” SEC v. Telegram

Grp. Inc., 2020 WL 3264264, at *1 (S.D.N.Y. June 17, 2020) (citing United States v. Amodeo,

71 F.3d 1044, 1051 (2d Cir. 1995)). For example, a proponent can demonstrate it has overcome

the presumption of public access by showing the documents in question “contain highly

proprietary material concerning . . . marketing strategies, product development, costs and

budgeting.” GoSMiLE, Inc. v. Dr. Jonathan Levine, D.M.D. P.C., 769 F. Supp. 2d 630, 649–50

(S.D.N.Y. 2011).

With respect to each motion, I have reviewed the applicable letter request,

supporting declarations, and exhibits, and conclude that maintaining the requested documents

and redactions under seal is warranted.

Accordingly, the requests to seal are granted. The Clerk shall terminate ECF Nos.

468, 472, 474, 485, 514, 517, 518, 519, 520, 521, 525, 529, 533, 536, and 542.

SO ORDERED.

Dated: May 25, 2022 ___________/s/_____________

New York, New York ALVIN K. HELLERSTEIN

United States District Judge

2

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.